Table 1 Node and edge overlap between individualized patient HCM networks.

From: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

Node overlap between individual-patient HCM networks

 

HCM 1

HCM 2

HCM 3

HCM 4

HCM 5

HCM 6

HCM 7

HCM 8

HCM 9

HCM 10

HCM 11

HCM 12

HCM 13

HCM 14

HCM 15

HCM 16

HCM 17

HCM 18

HCM 1

1

0.75

0.60

0.72

0.73

0.73

0.78

0.76

0.72

0.70

0.64

0.72

0.79

0.70

0.80

0.74

0.77

0.72

HCM 2

 

1

0.64

0.71

0.74

0.76

0.71

0.75

0.78

0.73

0.67

0.68

0.78

0.68

0.76

0.69

0.70

0.69

HCM 3

  

1

0.59

0.63

0.63

0.64

0.75

0.61

0.61

0.64

0.59

0.76

0.67

0.71

0.64

0.64

0.67

HCM 4

   

1

0.64

0.63

0.80

0.77

0.63

0.65

0.60

0.83

0.76

0.70

0.85

0.81

0.79

0.66

HCM 5

    

1

0.66

0.76

0.78

0.69

0.73

0.68

0.72

0.83

0.77

0.79

0.77

0.78

0.75

HCM 6

     

1

0.79

0.77

0.66

0.69

0.66

0.74

0.82

0.74

0.79

0.76

0.79

0.72

HCM 7

      

1

0.74

0.75

0.72

0.64

0.79

0.80

0.71

0.81

0.78

0.79

0.70

HCM 8

       

1

0.76

0.75

0.79

0.74

0.71

0.75

0.70

0.73

0.74

0.74

HCM 9

        

1

0.75

0.65

0.69

0.82

0.71

0.77

0.73

0.74

0.73

HCM 10

         

1

0.65

0.65

0.83

0.72

0.76

0.71

0.71

0.74

HCM 11

          

1

0.58

0.78

0.69

0.74

0.64

0.65

0.71

HCM 12

           

1

0.78

0.71

0.85

0.81

0.82

0.67

HCM 13

            

1

0.83

0.72

0.79

0.78

0.81

HCM 14

             

1

0.75

0.71

0.71

0.71

HCM 15

              

1

0.80

0.82

0.73

HCM 16

               

1

0.75

0.66

HCM 17

                

1

0.67

HCM 18

                 

1

Edge overlap between individual-patient HCM networks

 

HCM 1

HCM 2

HCM 3

HCM 4

HCM 5

HCM 6

HCM 7

HCM 8

HCM 9

HCM 10

HCM 11

HCM 12

HCM 13

HCM 14

HCM 15

HCM 16

HCM 17

HCM 18

HCM 1

1

0.56

0.32

0.54

0.56

0.57

0.59

0.44

0.53

0.50

0.37

0.51

0.50

0.42

0.51

0.52

0.56

0.48

HCM 2

 

1

0.32

0.47

0.53

0.59

0.49

0.40

0.60

0.56

0.39

0.46

0.49

0.39

0.46

0.41

0.45

0.42

HCM 3

  

1

0.30

0.36

0.36

0.32

0.40

0.33

0.32

0.35

0.26

0.39

0.31

0.32

0.29

0.30

0.36

HCM 4

   

1

0.45

0.44

0.65

0.46

0.42

0.39

0.30

0.73

0.45

0.41

0.66

0.66

0.61

0.38

HCM 5

    

1

0.47

0.57

0.48

0.51

0.52

0.43

0.52

0.58

0.54

0.52

0.56

0.59

0.52

HCM 6

     

1

0.62

0.47

0.48

0.49

0.42

0.56

0.56

0.51

0.54

0.56

0.61

0.50

HCM 7

      

1

0.42

0.55

0.51

0.33

0.67

0.55

0.46

0.57

0.61

0.65

0.46

HCM 8

       

1

0.43

0.43

0.51

0.44

0.37

0.42

0.33

0.41

0.41

0.43

HCM 9

        

1

0.56

0.38

0.46

0.55

0.41

0.47

0.48

0.52

0.48

HCM 10

         

1

0.40

0.41

0.58

0.44

0.45

0.45

0.47

0.51

HCM 11

          

1

0.29

0.48

0.38

0.37

0.31

0.32

0.44

HCM 12

           

1

0.53

0.47

0.68

0.67

0.69

0.42

HCM 13

            

1

0.66

0.37

0.54

0.52

0.58

HCM 14

             

1

0.45

0.48

0.47

0.48

HCM 15

              

1

0.57

0.61

0.40

HCM 16

               

1

0.57

0.40

HCM 17

                

1

0.40

HCM 18

                 

1

  1. The transcriptomic profile of anterior septal myectomy specimens from patients with hypertrophic cardiomyopathy (HCM) (N = 18) was analyzed using a two-step method that included a correlation matrix and protein–protein interaction analysis resulting in individualized patient networks. Nodes (representing proteins in the networks) common to individualized patient network pairs are presented in the top panel, and edges (representing interactions between proteins in the networks) common to individualized patient network pairs are presented in the bottom panel. 1, full overlap; 0, no overlap.